Year-end Sale % OFF 
Abstract
To determine the association between overall survival (OS) and two other endpoints, progression-free survival (PFS) and time to treatment failure (TTF), for patients with previously untreated advanced renal cell carcinoma. We used individual patient data from the intent-to-treat population (n=1096) in the CheckMate 214 study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
